| Sep 24 |
Empowering Women Entrepreneurs: 2024 BOTOX® (onabotulinumtoxinA) Cosmetic Grant Recipients Kick Off Crowdfunding Campaigns
|
| Sep 23 |
EMA Committee Endorses AbbVie's Elahere in Ovarian Cancer
|
| Sep 22 |
Is AbbVie (NYSE:ABBV) A Risky Investment?
|
| Sep 20 |
AbbVie Receives Positive CHMP Opinion for Mirvetuximab Soravtansine (ELAHERE®) for the Treatment of Certain Adult Ovarian Cancer
|
| Sep 19 |
2024 Election: Drug Prices Remain A 'Hot Topic.' Can Pharma Stocks Withstand The Pressure?
|
| Sep 19 |
2 Unstoppable S&P 500 Dividend Stocks to Buy Before They Beat the Market Again
|
| Sep 18 |
AbbVie (NYSE:ABBV) Expands Eye Care Portfolio with Ripple Therapeutics Collaboration, Boosts Growth Potential
|
| Sep 17 |
RHHBY or ABBV: Which Is the Better Value Stock Right Now?
|
| Sep 17 |
TransDigm, BJ's Wholesale, AbbVie And More On CNBC's 'Final Trades'
|
| Sep 16 |
Can AbbVie Regain Its Status As a Top Dividend Growth Stock?
|
